Morphobiochemical status of cows’ blood during therapy of subclinical mastitis with the complex ointment "Uberosept" together with immunomodulators
Open Access
- 24 January 2024
- journal article
- research article
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 4,p. 84-90
Abstract
The studies were conducted on lactating cows of Red-Motley Holstein and Simmental breeds with subclinical mastitis aged from 1 to 8 lactations. Four groups of animals of 10 animals each were selected. The first group was treated with the complex ointment “Uberosept” once a day, externally for 5 days. The second group received “Uberosept” 1 time per day, externally for 5 days, “Mixoferon” 3 ml intramuscularly 2 times a day for 7 days. The third group received “Uberosept” 1 time per day, externally for 5 days, “Submastin-KRS” 10 ml intramuscularly 1 time per day for 3 days. Blood samples were taken from all experimental groups to study morphobiochemical indicators and indicators of lipid peroxidation, antioxidant protection and endogenous intoxication. The samples were taken before treatment, immediately after the course of treatment and 7 days after treatment. The highest therapeutic effectiveness of the treatment regimen for subclinical mastitis used in the second experimental group was 90.0%. In the first experimental group, the therapeutic effectiveness was 60.0%, in the second experimental group - 80.0%. This was confirmed by morphobiochemical studies; in the group of animals that were injected with “Mixoferon” + complex ointment “Uberosept”, immunity indicators were higher than in the group of cows that were treated with “Submastin-KRS” + complex ointment “Uberosept”. At the same time, in the animals of the third experimental group, a more pronounced decrease in the processes of endogenous intoxication, lipid peroxidation and activation of antioxidant protection was observed.Keywords
This publication has 5 references indexed in Scilit:
- THERAPEUTIC EFFICACY OF THE DRUG “SUBMASTIN-СATTLE” FOR THERAPY OF SUBCLINICAL MASTITIS IN COWSTransactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine, 2022
- Intramammary treatment using allogeneic pure platelet-rich plasma in cows with subclinical mastitis caused by Gram-positive bacteriaScientific Reports, 2021
- MODERN ASSORTMENT OF ANTI-MASTITIS MEDICINES IN VETERINARY MEDICINEBULLETIN OF VETERINARY PHARMACOLOGY, 2020
- Control of Bovine Mastitis: Old and Recent Therapeutic ApproachesCurrent Microbiology, 2015
- Parenteral Treatment of Clinical Mastitis with Tylosin Base or Penethamate Hydriodide in Dairy CattleJournal of Dairy Science, 2007